@drjohnm @rajkumar_chris This seems pretty relevant, especially for those unfamiliar with subtraction anxiety: https://t.co/ChPgpSX1nD
'Faith Healing' and 'Subtraction Anxiety' in Unblinded Trials of Procedures: Lessons from DEFER and FAME-2 for End Points in the ISCHEMIA Trial.
Mentions
Extended reach
Total likes
Video views
Mentions per month
Jan 2019 – Mar 2025Where it's discussed
-
X / Twitter30 posts
-
News16 articles
-
Blogs5 articles
-
Facebook4 posts
-
YouTube3 videos
-
Reddit2 posts
AI synopsis
What people are saying
Several discussions highlight the importance of controlling for psychological biases in unblinded studies, with phrases like 'faith healing' and 'subtraction anxiety' used to emphasize how patient and doctor expectations can skew results. Words like 'problematic' and 'artifact' reflect critical engagement with trial methodology, while references to well-known studies, such as FAME 2 and ISCHEMIA, demonstrate a depth of understanding and concern about research validity. The tone varies from critical to inquisitive, reinforcing the perception that this publication adds valuable insights into improving clinical trial design and interpretation.
Most discussions acknowledge the challenges posed by psychological biases like faith healing and subtraction anxiety, with many aligning with the article's focus on trial design issues.
The posts demonstrate high curiosity, especially when explaining concepts like subtraction anxiety and referencing pivotal trials such as FAME 2 and ISCHEMIA.
Comments include references to specific trials, criticisms of methodology, and suggestions for better trial designs, indicating active and thoughtful engagement.
Participants appear to see the publication as relevant to ongoing debates about clinical trial reliability and interpretation, suggesting it influences perspectives on future research.
Abstract in brief
- The paper discusses how faith healing and anxiety about missing out on effective treatments can influence patient behavior and trial outcomes in unblinded clinical studies, using DEFER and FAME2 as examples.
- It highlights the challenges in designing trials where patients and doctors know the treatment assignments, which can affect the reliability of end points, especially in procedures like coronary interventions.
- The authors suggest that lessons from these trials can help improve the design and interpretation of future studies like ISCHEMIA, emphasizing the need for careful consideration of psychological factors and trial endpoints.]
Top posts
Most liked on X and Bluesky@GreggWStone @babytea96 @afshinfarzan @JACCJournals @djc795 @SVRaoMD @mmamas1973 @DrMarthaGulati @venkmurthy @ProfDFrancis @MortonKern Only true in unblinded studies due to subtraction anxiety https://t.co/Y0up992y3N. See ORBITA trial where there was no interaction between FFR or iFR, PCI and exercise time or angina frequency. https://t.co/vmIZLqiqTf
Next up, "‘Faith Healing’ and ‘Subtraction Anxiety’ in Unblinded Trials of Procedures" by @rajkumar_chris et al https://t.co/DYesetP98g
@btweeter82 FAME 2 was stopped early because a bogus endpoint called urgent revascularization was significantly increased in the OMT arm. This was an artifact of the lack of binding causing "subtraction anxiety " in the OMT arm. This is explained here. https://t.co/Y0up99k9sn
Well, well, well. Now those have you who have been following that naughty boy Chris Rajkumar (@rajkumar_chris), will know the correct answer to this. As you know, Chris wrote a disappointingly disrespectful and cheeky article in Circ CQO: https://t.co/5ZtRRBb9hr
@mikejohansenmd @MaartenvSmeden @rwyeh @ProfHayward @raj_mehta @CRichardsonmd Totally agree. In particular the combination of usual care control plus measurement error in dependent variable could create substantial biases, a la their myth #3 & subtraction anxiety. https://t.co/SA08w2lGAl
All mentions
Latest Insights in Cardiology: Ablation and PCI Updates
This week in Cardiology, Dr. John Mandrola discusses reader feedback on LGE pre-ICDs, PFA for AF ablation, and endovascular approaches for chronic total occlusions. This podcast is designed for healthcare professionals…
Early Aortic Valve Replacement Benefits in Asymptomatic Patients
The AVATAR trial investigated early surgical aortic valve replacement (SAVR) versus conservative treatment in asymptomatic patients with severe aortic stenosis. Results showed that early SAVR significantly reduced major…
Advances in Cardiology: AF Ablation and Hypertension Treatments
Renal denervation, AF ablation, and related developments are discussed by John Mandrola MD, focusing on clinical trial insights and treatment strategies for hypertension and atrial fibrillation.
@susan_bewley @HealthSenseUK @EvidenceMatters @NIHRresearch @Healthy_Control @GLADDUK Susan, any trial involving obvious changes may be biased by the outcomes for individuals, we call it "faith healing" and "subtraction anxiety" in cardiology can you see a design that will negate that? https://t.co/gf3q8hF9HJ
@BayswaterSG More than that, how can the trial be blinded? There are 2 well known concepts - Subtraction Anxiety and Faith Healing in treatments that are impossible to blind. It would be hard to think of a design that is not confounded by that. https://t.co/gf3q8hF9HJ
RT @GauravGulsin: @drjohnm @rajkumar_chris This seems pretty relevant, especially for those unfamiliar with subtraction anxiety: https://t…
@matiasrg @VictorDayan1 @clinicasac @SAC_54 I've just learnt a new concept: subtractionAnxiety . As @drjohnm said It's a good example. https://t.co/xjkb3Gf7Dw
RT @GauravGulsin: @drjohnm @rajkumar_chris This seems pretty relevant, especially for those unfamiliar with subtraction anxiety: https://t…
RT @GauravGulsin: @drjohnm @rajkumar_chris This seems pretty relevant, especially for those unfamiliar with subtraction anxiety: https://t…
Great point
@drjohnm @rajkumar_chris This seems pretty relevant, especially for those unfamiliar with subtraction anxiety: https://t.co/ChPgpSX1nD
Also read https://t.co/lV9roi06gm
https://t.co/TDRynmmCJa Telling patients they have no significant ischaemia by FFR is enough to reduce angina
‘Faith Healing’ and ‘Subtraction Anxiety’ in Unblinded Trials of Procedures | Circulation: Cardiovascular Quality and Outcomes https://t.co/qgHsbDADBt
@Medicinmanden Desuden er det problematisk at måle effekten af en større procedure vs. tabletter på et subjektivt endepunkt: https://t.co/4t5qrswa5l
RT @DavidLBrownMD: @spitzertweets @kaulcsmc @pash22 @ovidiogarciav @rahatheart1 @hect2701 @BCase07 @Ortega_Paz @sbrugaletta @sjorge4 @DFCap…
@spitzertweets @kaulcsmc @pash22 @ovidiogarciav @rahatheart1 @hect2701 @BCase07 @Ortega_Paz @sbrugaletta @sjorge4 @DFCapodanno @ESHLOF @Costa_F_8 @CRT_meeting @NielsRHolm @news_hart @lamelaspablo @ColletCarlos @RaberLorenz @VictorDayan1 @FaisalBakaeen @BiykemB @Vilavaite @MarionKCampbell https://t.co/Y0up99kHhV
@GreggWStone @babytea96 @afshinfarzan @JACCJournals @djc795 @SVRaoMD @mmamas1973 @DrMarthaGulati @venkmurthy @ProfDFrancis @MortonKern Only true in unblinded studies due to subtraction anxiety https://t.co/Y0up992y3N. See ORBITA trial where there was no interaction between FFR or iFR, PCI and exercise time or angina frequency. https://t.co/vmIZLqiqTf
@Shekarbohra @kaulcsmc @djc795 https://t.co/1EUvxksq0J.
@SossouMd @GabashaMD @OmarChehab1 @HeartDrTiffany @KevinRabii @CSmuclovisky Not "primarily" driven. Completely driven. https://t.co/Y0up99k9sn
@kaulcsmc @GreggWStone @GabashaMD @evandrofilhobr @KambisMashayek1 @DKarmpaliotis Subtraction anxiety. https://t.co/Y0up99k9sn
RT @DavidLBrownMD: @btweeter82 FAME 2 was stopped early because a bogus endpoint called urgent revascularization was significantly increase…
@btweeter82 FAME 2 was stopped early because a bogus endpoint called urgent revascularization was significantly increased in the OMT arm. This was an artifact of the lack of binding causing "subtraction anxiety " in the OMT arm. This is explained here. https://t.co/Y0up99k9sn
@NickJohnsonMD Telling people they had a good stress test reduced symptoms of chest pain. Presumably, telling kids they have inflammation around their heart will also induce some symptoms. https://t.co/IK3KPvYK26 https://t.co/tpVE30o6ii
Well, well, well. Now those have you who have been following that naughty boy Chris Rajkumar (@rajkumar_chris), will know the correct answer to this. As you know, Chris wrote a disappointingly disrespectful and cheeky article in Circ CQO: https://t.co/5ZtRRBb9hr
@egutibanes Faith healing and sustraction anxiety https://t.co/SESUEcyzam
@pomyers @djc795 @ProfDFrancis @bnallamo And here is the piece Francis' group corrected after the ISCHEMIA trialists' response: https://t.co/WRWeIlYEHe
@mikejohansenmd @MaartenvSmeden @rwyeh @ProfHayward @raj_mehta @CRichardsonmd Totally agree. In particular the combination of usual care control plus measurement error in dependent variable could create substantial biases, a la their myth #3 & subtraction anxiety. https://t.co/SA08w2lGAl
RT @willmeurer: “When the trial reports, we suggest that readers focus on the primary end point of cardiovascular death and nonfatal MI tha…
“When the trial reports, we suggest that readers focus on the primary end point of cardiovascular death and nonfatal MI that was originally pre-specified...” avoiding the subjective endpoints in an unblinded trial @SCTorg ISCHEMIA trial session https://t.co/iDxNB3PdVy #sct2019
@jehanalladina @ChrisWorsham @AnupamBJena Though the issue of chest pain and angina is probably even more complex than we like to believe (https://t.co/IIXQFLw2eJ). That said, as @ajaykirtane and many others (who have far more experience that I) have stated, there is a group of pts who don’t tolerate medical therapy well
"Faith healing" in medicine: "the simple act of telling a patient that the physiology test shows no significant ischemia dramatically improve[s] symptoms." -- @ProfDFrancis https://t.co/q434SOYnGb https://t.co/pDzrifm3OC
Next up, "‘Faith Healing’ and ‘Subtraction Anxiety’ in Unblinded Trials of Procedures" by @rajkumar_chris et al https://t.co/DYesetP98g